Skip to main content

Fenofibrate Tablets

Type of Posting: Revision Bulletin

Posting Date: 26–Jul–2013

Official Date: 01–Aug–2013

Archive Date: 09–Feb–2015

Expert Committee: Monographs—Small Molecules 2

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Fenofibrate Tablets monograph. The purpose of the revision is to add Dissolution Test 3 for a FDA approved generic product. Several minor editorial changes have been made to update the monograph to the current USP style.

The Fenofibrate Tablets Revision Bulletin supersedes the currently official monograph. This Revision Bulletin will be incorporated in First Supplement to USP 37–NF 32

Should you have any questions, please contact Sujatha Ramakrishna Ph.D., MBA (301-816-8349 or sxr@usp.org).